Introduction {#Sec1}
============

Adequate water intake is vital to health \[[@CR1]\]. Most frequently dehydration (i.e., measured total body water loss) is associated with changes to exercise performance, thermoregulation, or even immune function \[[@CR2], [@CR3]\]. However, within the general population, the term "underhydration" has been defined as chronic low water intake accompanied by increased concentration of urine and fluid regulatory hormones, but not necessarily with a measurable decrement to total body water \[[@CR4]\]. Defining underhydration is multidimensional, because the volume of water which is adequate for one individual can be substantially different from another due to extrinsic (e.g., environment) and intrinsic factors (e.g., physical activity, sodium, and caloric intake) \[[@CR5]\]. Individualized water recommendations use urine concentration measurements \[e.g., urine osmolality (*U*~osm~), urine-specific gravity (*U*~sg~), and urine color (*U*~col~)\] as physiological criteria of water intake adequacy \[[@CR6], [@CR7]\]. The rationale for their use is that observation of concentrated urine is an indication of negative free water clearance which assists with maintenance of total body water. Within the focus of underhydration, urinary evaluation provides more value to researchers compared to markers of dehydration (i.e., plasma osmolality and body mass change). Plasma osmolality is limited when evaluating changes in 24-h water intake, because it is tightly regulated across a wide range of water intake volumes \[[@CR8]\]. Body weight is less effective than urine evaluation, because it can fluctuate across days due to factors outside of water intake, such as caloric intake, particularly if measurements are greater than 1 day apart \[[@CR9], [@CR10]\]. Therefore, researchers have employed the *U*~osm~ threshold of 500 mOsm kg^−1^ within the general population as a reasonable target in the indication of adequate water intake, because *U*~osm~ accounts for factors such as body composition, dietary osmotic load, physical activity, and environment, and reflects the net result of urine concentrating and diluting mechanisms \[[@CR11]\].

While *U*~osm~ and *U*~sg~ are capable of identifying different categories of water intake \[[@CR12]--[@CR14]\], the required technical skills and equipment are often confined to clinical or research settings. *U*~col~, on the other hand, is self-assessable \[[@CR15]\] and has been correlated tightly with *U*~osm~ in previous studies \[[@CR16], [@CR17]\]. Furthermore, in adults and children, *U*~col~ alone offers the potential to identify underhydration \[[@CR7], [@CR15]\]. However, interpretation variation exists, because 24 h and single urine samples (i.e., spontaneous single samples) may be divergent \[[@CR18]\]. Within single *U*~col~ sample analysis, interpretation could also be altered depending on the use of first morning \[[@CR19]\] or early afternoon samples \[[@CR20]\] as representation of adequate fluid intake. In addition, although the directionality of the *U*~col~ and water intake relationship is apparent; the full value of *U*~col~ has yet to be realized, because the volume of water that should be consumed to return to euhydration following a decrease in habitual water intake and the consequential underhydration or dehydration has not been defined.

Efforts have been made to quantify the volume of water necessary to change *U*~col~. A secondary, pooled analysis performed by Perrier et al. \[[@CR21]\] combined studies in which daily total water intake (TWI) was manipulated, showing that an increase in TWI of 1110 mL day^−1^ \[95% CI 914--1306\] was required to lighten *U*~col~ by two units. Although useful, these results were limited, because (a) the volumes of TWI change that were pooled were generally large (i.e., \> 1000 mL day^−1^), (b) the pooled sample populations were heterogeneous, and (c) the study only evaluated changes in *U*~col~ of two units which is not necessarily equivalent to an individual moving from above the *U*~col~ adequate water intake threshold of "4" on an eight-point scale \[[@CR7]\], to below that threshold.

U~col~ thus appears to be particularly suited for applied self-evaluation outside of a research laboratory. However, inconsistencies in past investigations \[[@CR19], [@CR22], [@CR23]\] as well as differentiation between dehydration and underhydration \[[@CR4]\] point towards the need for additional and more specific research into the question of how to validly apply urinary markers to determine if, when, and how an individual has returned to adequate water intake following a period of insufficient intake. Therefore, the following investigation had three purposes: (a) to evaluate changes in hydration biomarkers in response to graded rehydration following 3 days of water restriction (WR), (b) assess within-day variation in urine concentration, and (c) quantify the volume of fluid needed to return to a urinary concentration associated with adequate water intake (i.e., a *U*~col~ of \< 4 \[[@CR7]\]) as demonstrated by change in *U*~col~. We hypothesized in reference to the above aims that (a) most participants would exhibit biomarkers indicative of underhydration following 3 days of WR and that there would be a progressive increase in the number of well hydrated individuals following the rehydration protocol, (b) urine concentration would be associated with the cumulative volume of water consumed over the progression of the day with the most concentrated occurring in the morning and least in the mid-day, and (c) at least 1000 mL of additional water would be needed to return and individual to *U*~col~ \< 4.

Subjects, materials, and methods {#Sec2}
================================

Subjects {#Sec3}
--------

125 healthy men and women between the ages of 18 and 45 years participated in the current study. Of these, ten participants were excluded for the following reasons: failure to follow WR protocol (*n* = 1), failure to provide sufficient single urine samples (at least four of the six samples required by the protocol on all days; *n* = 8), and failure to return final dietary log (*n* = 1) (Fig. [1](#Fig1){ref-type="fig"}). Criteria for exclusion from this study included evidence of clinically relevant disease, regular prescription drug treatment that could disrupt fluid balance, body mass change (\> 2.5 kg) or noteworthy dietary modifications in the past month, and exercising \> 4 h per week. All of these factors were chosen, because they could potentially alter normal body water regulation. The University of Wyoming institutional review board approved this study protocol (protocol \#20160524EJ01208), and all participants provided written informed consent in accordance with the Declaration of Helsinki. Each participant received financial compensation commensurate with the amount of time required for participation in the study.Fig. 1Flow diagram of subject recruitment

Study design {#Sec4}
------------

This study was an open-label, randomized-controlled trial, divided into two phases: "Baseline" which took place during week 1 where participants maintained normal eating and drinking habits, and "Experimental" which took place during week 2 where participants' daily water intake was prescribed. During the experimental week, all participants were asked to refrain from traveling to a location that was more than 600 m different in elevation from Laramie, WY (elevation 2200 m), because abrupt changes in altitude may influence water balance \[[@CR24]\]. Women's participation in the study was not standardized for phase of menstrual cycle for two reasons. First, the purpose of this investigation was to provide ecologically valid recommendations for changes in water intake, which would not have been possible if all women participated during the identical phase of their menstrual cycle. Second, while the evidence of exogenous hormones influences on the set points for body fluid volume and tonicity, regulation is strong \[[@CR25]\]. These changes do not appear to cause changes in total body water or renal free water clearance \[[@CR26]--[@CR28]\]. All participants completed five visits, two during Baseline and three during Experimental, to the Human Integrated Physiology Laboratory at the University of Wyoming. Outside of laboratory visits, participants recorded all food and fluid intake over the course of 12 consecutive days and collected 24-h urine samples on 4 days. The experimental conditions of the Baseline week were identical for all participants. The first 3 days of the Experimental week required all participants to limit their total fluid consumption to 1000 mL H~2~O day^−1^ (water restriction), with no other beverages, to elicit physiological water conservation consistent with elevated concentrations of the fluid conservation hormone vasopressin \[[@CR29]\]. Participants received instructions as to what times during the day specific volumes of water were to be consumed. During 3 days of WR, the 1000 mL H~2~O day^−1^ was split into four equal 250 mL servings and consumed as follows: 250 mL with breakfast, 250 mL with lunch, 250 mL with dinner, and 250 mL before retiring to bed. On day 4 of Experimental week, participants were randomly assigned into one of the five groups of the graded rehydration intervention (GRHI): maintain 1000 mL H~2~O day^−1^ (CON group, 1000 mL H~2~O day^−1^ with no additional water) or increase their daily water intake corresponding to their randomly assigned group: additional 500 mL H~2~O day^−1^ (*G*~+0.50~), additional 1000 mL H~2~O day^−1^ (*G*~+1.00~), additional 1500 mL H~2~O day^−1^ (*G*~+1.50~), or additional 2250 mL H~2~O day^−1^ (*G*~+2.25~). Additional water was divided into three identical servings (e.g., *G*~+1.00~, 3 × 330 mL servings were given) and consumed at the following times, (1) additional morning water after the first single urine sample and at least 30 min before lunch, (2) additional afternoon water after the third single urine sample and at least 30 min before dinner, and (3) additional evening water after the fifth single urine sample and at least 30 min before retiring to bed. Single urine collection timing is described below.

Experimental measurements {#Sec5}
-------------------------

During the initial visit, participants completed an informed consent, medical history questionnaire, and had anthropometric measurements obtained, including body composition analysis with a DXA scanner (Lunar Prodigy; General Electric Healthcare). This initial visit marked the first day of food and fluid diary recording which continued throughout all 12 days of the study. On visits 2--5, participants returned the previous days' 24-h urine sample to the laboratory for analysis. On visit three, four, and five, single samples were collected at six pre-determined times; (1) within 20 min after breakfast, (2) just before lunch and before 2nd 250 mL water, (3) within 20 min after lunch, (4) just before dinner and before third 250 mL water, (5) within 20 min after dinner, and (6) just before retiring to bed and before fourth 250 mL water. Each single sample was analyzed individually. Then, the specifically timed single samples were combined with voids that may have come between (which were collected in a single separate container), to reflect a complete 24 h collection. Any missing specimens (due to inability of participant to produce sample during WR) were indicated on the data sheet.

Each urine sample was analyzed for the following indices: *U*~osm~ using freezing point depression osmometry (Advanced Instruments Model 3250, Norwood, MA, USA), *U*~sg~ using manual refractometer (ATAGO T3-NE, Atago Corp., Japan), and *U*~col~ using the eight-point urine color scale (HydrationCheck.com) \[[@CR30]\]. Urine specimens were excluded from urine color analysis if there was evidence of heavy menstrual bleeding (*n* = 1).

Participants recorded food intake using a 24-h diet diary on each day of the study, totaling 12 days. Fluid intake was separately recorded concurrently by participants using validated 24-h fluid diary \[[@CR31]\]. Foods with high water content, such as soup, were not recorded in the fluid diary, but in the food diary. All information recorded in the fluid questionnaire and diet diaries were entered into the Nutritional Data System for Research software (Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN, USA) to determine macronutrient, water, and sodium content. TWI was calculated by adding water from food to water intake from all beverages using data from both the diet and fluid diaries.

Due to the subjective nature of urine color assessment, all specimens had *U*~col~ assessed by a single researcher, under similar light conditions to avoid inter-rater differences in color ratings. In addition, an intra-rater reliability analysis was conducted to determine the precision of color ratings when confined to a single researcher. Thirty-one individual urine samples were presented to the *U*~col~ researcher in a random order and blinded by assigning letter and number combination codes. *U*~col~ of each of the 31 samples was assessed by the researcher on three separate occurrences 1 h apart, in between which the order of samples was re-randomized and assigned new identification codes.

Statistical analyses {#Sec6}
--------------------

Sample size was calculated with the use of G\*Power 3.0.10 (Franz Faul, Universitat Kiel, Germany) based on planned independent *t* tests between two means and the known volume change in water needed to lighten *U*~col~ by two units (power at 0.95, and *α* = 0.05). A sample size of 15 in each rehydration group was necessary to identify a meaningful difference of 1092 mL between groups, assuming an 877 mL standard deviation of the volume of water previously reported to lighten*U*~col~ by two units \[[@CR21]\]. Based on previous studies and due to the time demands associated with data collection, we assumed that about 30% of the sample population either would choose to stop participation in the study, or would not adhere to all study requirements (e.g., incomplete dietary records). Therefore, we enrolled 25 participants in each rehydration group for a total of 125 study participants.

Data analysis was performed using, SPSS (IBM v24, Armonk, NY, USA). Intraclass correlation coefficient (ICC) analysis was used to determine intra-rater reliability for *U*~col~ assessment \[[@CR32]\]. Cronbach's *α* is representative of the lower bound internal consistency of a test or scale. ICC values less than 0.5 are indicative of poor reliability, values between 0.50 and 0.75 indicate moderate reliability, values between 0.75 and 0.90 indicate good reliability, and values greater than 0.90 indicate excellent reliability \[[@CR33]\]. For purpose "A", one-way ANOVAs were used to determine differences between demographic baseline variables for normally distributed variables, while Wilcoxon rank sum tests were used for non-normally distributed variables and Ucol because it is ordinal rather than continuous. Two-way repeated-measures ANOVAs \[group (5) × time (3 or 2)\] were used to establish main effects of time or group membership for all hydration-related variables. One test was performed for each variable between baseline and the end of the WR period. A second two-way ANOVA was performed between the end of WR and the day of the GRHI. Two ANOVAs were used for each variable, because the directionality of change would be expected to proceed in opposite directions between each of the above identified time courses. In the case of a statistically significant main effect of group, or interactions between group and time, post hoc independent samples *t* tests with Bonferroni corrections were used to define individual differences within *U*~osm~ and *U*~sg~, and post hoc Wilcoxon rank sum tests with correction for multiple comparisons were used for non-normally distributed variables and *U*~col~, between groups on visit 5 (i.e., the day of the GRHI). For purpose "B", fluctuations in individual single urine osmolalities on the day of the GRHI were analyzed by two-way repeated-measures ANOVA \[group (5) × time (6)\]. Following significant interaction between group and time, post hoc independent samples *t* tests with Bonferroni corrections were used to define individual differences within *U*~osm~ at each time point. Finally, for purpose "C", the return to adequate urine color was analyzed by separating out only those within the total sample whose 24 h *U*~col~ rose to \> 4 (i.e., evidence of underhydration) on the third day of WR (*n* = 84), while those whose *U*~col~ remained ≤ 4 were eliminated from further analysis for purpose "C". Next, during the GRHI, participants whose 24 h *U*~col~ dropped to \< 4 were classified as adequately hydrated (*n* = 26), while those whose *U*~col~ remained ≥ 4 continued to be classified as underhydrated (*n* = 58). In an effort to perform the most conservative calculations, individuals with *U*~col~ = 4 were not classified as underhydrated following WR and were not classified as adequately hydrated following the GRHI, because *U*~col~ of 4 has previously been determined to be the criterion value between the classifications \[[@CR7]\]. Change in TWI for all individuals was calculated by subtracting TWI on the final day of WR from TWI on the day of the GRHI. Change in TWI volume was compared between those who successfully moved from underhydrated to adequately hydrated due to the intervention versus those who remained underhydrated with an independent samples *t* test. Statistical significance was set a priori at *α* \< 0.05, and all values are displayed as mean ± standard deviation unless otherwise noted.

Results {#Sec7}
=======

Baseline results {#Sec8}
----------------

All participants' baseline demographic and hydration information is shown in Table [1](#Tab1){ref-type="table"}. No significant differences were observed between groups for any variables (all *p* \> 0.093). The analysis of 31 individual urine specimens at three separate time points indicated high reliability of the *U*~col~ rater, Cronbach's *α* = 0.993 (95% CI 0.987--0.996) *F*~\[30,60\]~ = 142.4, *p* \< 0.001.Table 1Participant demographicsCON*G*~+0.50~*G*~+1.00~*G*~+1.50~*G*~+2.25~*p* value*N* (%female)25 (52%)22 (50%)23 (43%)22 (55%)23 (43%)--Age (years)31 ± 931 ± 932 ± 831 ± 832 ± 90.997\*Height (cm)174 ± 9172 ± 9177 ± 10172 ± 11171 ± 110.337Weight (kg)75.7 ± 17.973.8 ± 20.079.9 ± 14.870.8 ± 11.671.6 ± 22.40.152\*BMI (kg m^−2^)25.1 ± 5.124.8 ± 5.125.6 ± 4.023.8 ± 2.724.1 ± 4.80.518\*Body fat (%)28.5 ± 9.628.4 ± 7.829.9 ± 11.727.3 ± 8.425.4 ± 9.70.589Urine osmolality (mOsm kg^−1^)639 ± 299555 ± 317597 ± 271566 ± 304512 ± 3530.617\*Urine color4 ± 23 ± 25 ± 24 ± 24 ± 20.093\*Urine specific gravity1.016 ± 0.0081.014 ± 0.0081.015 ± 0.0071.015 ± 0.0081.013 ± 0.0100.652\*Wilcoxan rank sum test. All urine measurements taken from single urine samples provided during habitual dietary intake

Water restriction {#Sec9}
-----------------

A significant main effect of time for TWI demonstrated that the WR protocol was successful in reducing all groups' TWI from a grand mean of 3323 ± 1230 mL day^−1^ during the baseline observation period to 1730 ± 289 mL day^−1^ during the 3 days of WR (Table [2](#Tab2){ref-type="table"}). Concomitantly, the grand mean of body mass significantly decreased (73.8 ± 16.3 to 73.4 ± 16.1 kg; *F*~\[1,104\]~ = 9.8, *p* \< 0.001), while the grand means of all 24 h urinary markers of hydration increased; *U*~osm~ (465 ± 234 to 782 ± 213 mOsm kg^−1^; *F*~\[2,\ 220\]~ = 173.4, *p* \< 0.001), *U*~col~ (3 ± 1 to 5 ± 1; *F*~\[2,\ 216\]~ = 127.5, *p* \< 0.001), and *U*~sg~ (1.012 ± 0.006 to 1.021 ± 0.005; *F*~\[2,\ 220\]~ = 187.1, *p* \< 0.001), as evidenced by significant main effects of time reported above for each of the variables. No significant main effects of group or interactions between group and time were observed. On the final day of WR, 84 of the 115 participants (73%) produced a 24 h urine sample with *U*~col~ \> 4 (i.e., 5, 6, 7, or 8). This demonstrated that the WR protocol produced underhydration similarly in all five groups and that a large majority of participants were producing concentrated urine which was indicative of inadequate water intake.Table 2Water intake and corresponding markers of hydrationBaselineWater restriction\
Day 1Water restriction\
Day 2Water restriction\
Day 3Post-graded rehydration interventionTotal water intake^a^ (mL day^−1^) CON3382 ± 12861750 ± 2771743 ± 2601779 ± 3351726 ± 297\* *G*~+0.50~3248 ± 9411700 ± 3451681 ± 3001820 ± 4192205 ± 342\* *G*~+1.00~3376 ± 11831721 ± 3311784 ± 4161758 ± 2482676 ± 336\* *G*~+1.50~3684 ± 16211734 ± 4651661 ± 3151794 ± 4903118 ± 291\* *G*~+2.25~2930 ± 9891667 ± 2501692 ± 2601666 ± 1883807 ± 184\* Main effect of group0.426\< 0.001 Main effect of time\< 0.001\< 0.001 Interaction group × time0.443\< 0.001Body mass^b^ (kg) CON75.8 ± 18.1----75.8 ± 18.575.8 ± 18.2 *G*~+0.50~71.7 ± 15.0----71.1 ± 14.571.3 ± 14.6 *G*~+1.00~79.8 ± 14.6----79.4 ± 14.379.3 ± 14.6 *G*~+1.50~70.8 ± 11.7----70.4 ± 11.770.4 ± 11.8 *G*~+2.25~68.4 ± 14.3----67.8 ± 14.068.3 ± 14.3 Main effect of group0.0860.089 Main effect of time\< 0.0010.063 Interaction group × time0.5840.232Urine osmolality (mOsm kg^−1^) CON525 ± 291--810 ± 198834 ± 223873 ± 226^3,4,5^ *G*~+0.50~474 ± 218--729 ± 247839 ± 222704 ± 254^4,5^ *G*~+1.00~457 ± 205--700 ± 211766 ± 255613 ± 315^1^ *G*~+1.50~416 ± 226--783 ± 207793 ± 240502 ± 250^1^ *G*~+2.25~446 ± 219--769 ± 222791 ± 268452 ± 284^1,2^ Main effect of group0.6810.004 Main effect of time\< 0.001\< 0.001 Interaction group × time0.881\< 0.001Urine color CON4 ± 1--5 ± 15 ± 16 ± 1^3,4,5^ *G*~+0.50~3 ± 1--5 ± 15 ± 15 ± 1^5^ *G*~+1.00~3 ± 1--5 ± 15 ± 14 ± 2^1,5^ *G*~+1.50~4 ± 1--5 ± 16 ± 14 ± 2^1^ *G*~+2.25~3 ± 1--5 ± 15 ± 13 ± 2^1,2,3^ Main effect of group0.4950.001 Main effect of time\< 0.001\< 0.001 Interaction group × time0.836\< 0.001Urine-specific gravity CON1.014 ± 0.007--1.021 ± 0.0051.022 ± 0.0061.023 ± 0.006^4,5^ *G*~+0.50~1.012 ± 0.005--1.019 ± 0.0061.022 ± 0.0061.019 ± 0.006^5^ *G*~+1.00~1.012 ± 0.005--1.019 ± 0.0051.020 ± 0.0061.016 ± 0.007^1^ *G*~+1.50~1.011 ± 0.006--1.021 ± 0.0051.021 ± 0.0061.014 ± 0.007^1^ *G*~+2.25~1.012 ± 0.006--1.020 ± 0.0061.021 ± 0.0051.011 ± 0.008^1,2^ Main effect of group0.6480.003 Main effect of time\< 0.001\< 0.001 Interaction group × time0.411\< 0.001All urinary measurements are from 24 h samples^1,2,3,4,5^Wilcoxon rank sum post hoc test significantly different than CON, *G*~+0.50~, *G*~+1.00~, *G*~+1.50~, *G*~+2.25~, respectively\*Post hoc independent samples *t* test significantly different than all other groups at time point^a^Baseline total water intake is average daily water intake over the 7 days of initial observation^b^Body mass measurements occurred during the day. The body mass taken on the day of the graded rehydration intervention was only partially through the day; therefore, the body mass of the day after the graded rehydration intervention is reported here

Increased water intake {#Sec10}
----------------------

Significant main effects of time, group, and a significant interaction between these factors demonstrated that the GRHI successfully changed each groups' TWI. Post hoc *t* tests revealed that all groups' TWI on the day of the GRHI were indeed significantly different from all other groups (all *p* \< 0.001). Body mass did not significantly change in response to increased water intake. However, within urinary markers, main effects of time, group, and significant interactions between these factors demonstrated that makers related to water intake adequacy were changed by the water intervention (Table [2](#Tab2){ref-type="table"}). Post hoc analyses revealed that typically groups whose rehydration intervention was only one intake volume step away (e.g., *G*~+0.50~ versus *G*~+1.00~) were not statistically different. At the end of the GRHI, 24 h urine samples differentiated both *G*~+1.50~ and *G*~+2.25~ from CON for all markers of hydration (Table [2](#Tab2){ref-type="table"}).

Individual single urine samples collected on the day of the GRHI revealed that differences in 24 h *U*~osm~ were particularly attributable to individual time points within groups *G*~+1.50~ and *G*~+2.25~ (Fig. [2](#Fig2){ref-type="fig"}). A significant interaction (*F*~\[4,108\]~ = 2.767, *p* = 0.031) between group and time demonstrated that the GRHI changed *U*~osm~ differently between groups over the course of the day. Generally speaking, differences between groups tended to emerge later in the day. Specifically, post hoc tests showed that *G*~+1.50~*U*~osm~ was different from that of CON within single urine samples provided after breakfast, after lunch, and before bed, and different from *G*~+0.50~ after lunch only. Group *G*~+2.25~ was different from CON when samples were collected after lunch, after dinner, and before bed. In addition, *G*~+2.25~*U*~osm~ was significantly lower than *G*~+0.50~ after lunch and before bed, and lower than *G*~+1.00~ before bed (all *p* \< 0.039, after corrections for multiple comparisons).Fig. 224-h urine osmolality for 2 final days of water restriction (WR) and single urine osmolality for six time points on day of graded rehydration intervention. ^1,2,3^Post hoc independent samples *t* test significantly different than CON, *G*~+0.50~, and *G*~+1.00~, respectively

Average amount of extra water needed to change UC from \> 4 to \< 4 in 24 h {#Sec11}
---------------------------------------------------------------------------

To assess the volume of water required to change from *U*~col~ \> 4 to \< 4, the effect of the GRHI was evaluated on those individuals whose *U*~col~ was \> 4 after fluid restriction (Fig. [3](#Fig3){ref-type="fig"}). The individuals (*n* = 31) whose *U*~col~ did not exceed 4 during WR were eliminated from the following analyses. Of the 84 participants with *U*~col~ \> 4 at the end of WR, only a minority (*n* = 26, or 30%) returned to *U*~col~ \< 4 after the GRHI (Fig. [3](#Fig3){ref-type="fig"}). Those who returned to *U*~col~ \< 4 more frequently came from the two subgroups with the highest water intake (19/26 from groups *G*~+2.25~ or *G*~+1.50~) than from the subgroups with lower water intake (7/26 from *G*~+1.00~ or *G*~+0.50~). On average, those who successfully returned to a urine concentration associated with adequate water intake (*U*~col~ \< 4) consumed a TWI of 3253 ± 649 mL (TWI∆, 1435 ± 812 mL), while those who failed to return to adequate intake consumed significantly less (TWI, 2411 ± 689 mL; TWI∆ +667 ± 722 mL; both *p* \< 0.001). Nineteen individuals in CON demonstrated *U*~col~ \> 4 after 3 days of WR and none of these individuals reduced *U*~col~ \< 4 on the GRHI day (for CON maintenance of 1000 mL H~2~O day^−1^ water intake). For each intervention group, 0%, 32%, 26%, 59%, and 65% for CON, *G*~+0.50~, *G*~+1.00~, *G*~+1.50~, and *G*~+2.25~, respectively, demonstrated *U*~col~ \< 4 on the day of the GRHI.Fig. 324-h urine color progression due to water restriction and graded rehydration intervention. The mean *U*~col~ for each grouping is represented by the "X" each box. The median is the middle line within each box. The 25th and 75th percentiles are represented by the top and bottom horizontal lines of each box. In some cases, the 25th percentile, median, and/or 75th percentile were equal due to the ordinal nature of *U*~col~. All dashed arrow lines are drawn to and from the median of each grouping. The range of each grouping is represented by the height of the error bars. Changes in TWI are indicated on each line between boxes with + and − signs indicating increased or decreased TWI, respectively

Discussion {#Sec12}
==========

The main findings of the current investigation were (a) 1000 mL day^−1^ of water administered over 3 days was sufficient to induce urinary markers consistent with inadequate fluid intake (i.e., elevated urine osmolality) in most, but not all participants and that approximately 1500 mL day^−1^ of additional water was required during the GRHI to reduce urine concentration below that of CON, (b) fluctuations in *U*~osm~ coincided with the timing and the compounded volume of additional water given on the day of the GRHI, and (c) an increase of water intake between 1107 and 1763 mL day^−1^, in addition to the baseline intake of 1000 mL day^−1^, is required to reduce an individual's *U*~col~ from \> 4 to \< 4 within 24 h. These findings expand upon previous water intake investigations by allowing precise observation of the responses to graded rehydration and quantification of water volumes that are necessary to re-establish urinary concentration consistent with adequate water intake.

Following 3 days of WR, a majority of individuals displayed not only signs of inadequate water intake (i.e., elevated urine concentration), but those of dehydration (e.g., decrease of body mass). During the period of WR, individuals consumed only 1000 mL day^−1^ of plain water, and the remainder of their TWI (\~ 700 mL day^−1^) came from food sources (e.g., fruit, soups, etc.). Our measurements did not include an estimation for metabolic water production. TWI was below both the U.S. National Academy of Medicine (3000--3700 mL day^−1^) \[[@CR5]\] and the European Food Safety Authority (EFSA, 2000--2500 mL day^−1^) \[[@CR34]\] adequate intake recommendations for females and males. The finding that most but not all individuals displayed signs of underhydration due to this WR provides two items of significance. First, this supports both above adequate intakes, because 1700 mL day^−1^ of TWI is not adequate among a selected sample of healthy individuals. However, it also demonstrates the variability in water needs across individuals. Even though the mean intake during baseline was nearly double the volume provided during WR, underhydration was not apparent in all individuals, which may be indicative of the extrinsic and intrinsic factors related to total water needs (e.g., environmental heat exposure or lean body mass, respectively).

The graded rehydration was important, because several past investigations specific to the relationship between water intake and hydration biomarkers have identified "high" and "low" drinkers, and then evaluated changes that occurred when TWI volumes are switched \[[@CR12], [@CR18], [@CR35]\] (i.e., a change in TWI of \> 1000 mL day^−1^). Although this approach is beneficial for evaluation of the largest and smallest TWI groups, its applicability is limited. It would be helpful to know if moderate increases in water intake could shift hydration biomarkers towards values associated with adequate water intake, because water interventions that impose large changes in TWI could be met with resistance by users. In this investigation, the group which received the smallest increase in water intake during the GRHI (*G*~+0.50~) realized no benefit due to the additional water, as evaluated by urinary biomarkers. This is similar to past research which found no differences in urinary or hematological biomarkers of hydration state after increasing chronic water intake over the course of 2 weeks from 35 to 40 mL kg^−1^ body mass (1685 ± 320 to 2054 ± 363 mL day^−1^) \[[@CR36]\]. Although there may be physiological benefits of increasing water intake by volumes even as small as 100 mL, such as suppression of vasopressin secretion or exercise performance enhancement \[[@CR37], [@CR38]\], it is clear that urinary biomarkers of water intake cannot differentiate these small changes due to the relatively small samples sizes that were investigated.

In contrast to the lower volumes of GRHI that did not induce changes in urinary markers, the higher volumes resulted in significant changes. As mentioned above, approximately 1100 mL of additional water was previously recommended to decrease *U*~col~ by two units \[[@CR21]\]. Our findings support these previous studies, because the low end of the 95% CI associated with moving from a *U*~col~ \> 4 to \< 4 was 1107 mL and the upper end of the 95% CI was 1763 mL. While this is a large range encompassing 600 mL (just over two 8 oz glasses), it reflects the range of *U*~col~ that was induced by the WR. In the previous study, the 1100 mL was associated only with a decrease of *U*~col~ by two units. This would only be applicable to the current investigation if that participant were moving from *U*~col~ = 5--3. The present findings also can be applied to an individual moving from *U*~col~ = 7 to *U*~col~ = 3. However, it is clear that even 2250 ml of additional water was not sufficient for some, as evidenced by the 35% of *G*~+2.25~ whose *U*~col~ remained ≥ 4 following GRHI. Because the GRHI took place over a single 24 h period, it is possible that a second day of increased water intake within many of the intervention groups may have allowed those participants to return to *U*~col~ \< 4. Although from a different geographical population, the finding that free-living individuals with habitual TWI \> 2500 mL day^−1^ were associated with optimal hydration \[[@CR39]\] supports the theory that a longer duration of *G*~+1.50~ or *G*~+2.25~ GRHI would have been successful in returning a greater proportion to more desirable urine concentrations.

Factors such as (1) the relatively small gradations between the GRHI groups and (2) a sample population with a wide range of ages, body masses, and an equal distribution of both sexes make this investigation strong. However, there are also several limitations that are acknowledged. For example, the evidence of underhydration induced by WR over 3 days is a unique protocol. It is not clear if the urinary values associated with the WR or the GRHI would be similar if the alterations of fluid balance were induced over a shorter duration or as the result of chronic or habitual low intake. While the evidence of underhydration was strong, it was also assumed as evidenced by body mass measurements that dehydration was imparted by the WR protocol. However, the lack of increase in body mass following the GRHI, even in groups receiving higher volumes of water (e.g., *G*~+1.50~), makes it plausible that the − 0.4-kg change in body mass that was observed did not represent a loss of total body water and thus increased water intake would not influence body water. In this case, it is likely that the reduced urinary concentration markers were indicative of additional water excretion only and not changes in hydration status. This may be important, because both hydration status (i.e., total body water volume) and hydration process (i.e., daily water turnover) have been implicated in relationships with overall health \[[@CR40]\]. It appears as if the present intervention is most relevant to the latter. A second limitation of this investigation is the self-report nature of the dietary logs. Finally, the limitations of self-report food logs are well documented, and thus, the reported values for macronutrient intake reported within this investigation should be viewed as an estimation.

The results of this investigation can be applied to a number of situations. For example, health care workers who demonstrate poor hydration practices \[[@CR41]\] can be coached to evaluate their *U*~col~. In the case of noticing a darker *U*~col~ at the end of a work shift, the volume of additional water that should be consumed to achieve ideal urine concentration is now understood. Moreover, as increased water intake has been shown to significantly reduce the incidence of urinary tract infection (UTI) recurrence \[[@CR42]\], these results may help young women who suffer from recurrent UTI to manage their fluid intake appropriately for secondary UTI prevention. Overall, the data of the present study provide a starting point regarding the optimization of water intake within populations known to exhibit increased urinary concentration, as well as within individuals seeking to improve their hydration status within a 24-h period.

CON

:   Control group, no additional water during rehydration phase

*G*~+0.50~

:   Additional 500 mL (0.50 L) water during rehydration phase

*G*~+1.00~

:   Additional 1000 mL (1.00 L) water during rehydration phase

*G*~+1.50~

:   Additional 1500 mL (1.50 L) water during rehydration phase

*G*~+2.25~

:   Additional 2250 mL (2.25 L) water during rehydration phase

GRHI

:   Graded rehydration intervention

TBW

:   Total body water

TWI

:   Total water intake, water from food, and beverages

TWI∆

:   Change in total water intake either between baseline and water restriction or between water restriction and the graded rehydration intervention

*U*~osm~

:   Urine osmolality (mOsmo kg^−1^)

*U*~vol~

:   Urine volume (mL)

*U*~sg~

:   Urine-specific gravity

*U*~col~

:   Urine color

WR

:   Water restriction
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